Endexx Competitors

Pink Sheets . USA . 
Stock . Endexx Corp
EDXC Stock  USD 0.01  0.0003  2.91%   
Endexx Corp competes with CbdMD, Evolus, Akanda Corp, Biofrontera, and Collegium Pharmaceutical; as well as few others. The company conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Endexx Corp competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Endexx Corp to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Endexx Corp Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Endexx Corp competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Endexx Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.018.39
Details
Intrinsic
Valuation
LowRealHigh
0.000.018.39
Details

Endexx Corp Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Endexx Corp and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Endexx and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Endexx Corp does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
COLL
+ 0.85
AKAN
INCR
+ 0.85
AKAN
COLL
+ 0.82
EOLS
INCR
+ 0.82
COLL
INCR
+ 0.71
EOLS
BFRI
+ 0.65
AKAN
  
High negative correlations   
INCR
- 0.0
HENC
ANIP
- 0.0
HENC
COLL
- 0.0
HENC
BFRI
- 0.0
HENC
AKAN
- 0.0
HENC
CVSI
- 0.0
HENC

Risk-Adjusted Indicators

There is a big difference between Endexx Pink Sheet performing well and Endexx Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Endexx Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Endexx Corp Competitive Analysis

The better you understand Endexx Corp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Endexx Corp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Endexx Corp's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
EDXC HENC YCBD EOLS CVSI AKAN BFRI COLL ANIP INCR
 2.91 
 0.01 
Endexx
 0.00 
 0.0001 
Holloman
 3.92 
 0.49 
CbdMD
 0.80 
 13.69 
Evolus
 0.00 
 0.04 
CVSI
 2.94 
 1.75 
Akanda
 9.09 
 0.90 
Biofrontera
 0.68 
 30.50 
Collegium
 3.64 
 57.23 
ANI
 1.48 
 1.33 
INC
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Extremely Dangerous
Not too volatile
Out of control
Dangerous
Unstable
Very steady
Very steady
Slightly risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Below Average
Very High
Below Average
Below Average
Very High
Very High
Very Low
Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Buy
Strong Buy
Not Available
Not Available
Strong Buy
Buy
Buy
Strong Sell
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Hold
Strong Sell
Cautious Hold
Hold
Hold
Current Ratio
0.05
0.8
3.47
2.6
0.93
0.48
3.16
0.99
3.35
1.87
Net Asset
5.22 M
186.91 K
16.2 M
189 M
18.07 M
8.84 M
27.93 M
1.14 B
904.42 M
786.61 M
Profit Margin
N/A
N/A
-0.94
-0.22
-0.85
N/A
-0.38
0.15
-0.0128
-0.24
EBITDA
(2.87 M)
(3.46 M)
(7.47 M)
(41.81 M)
(14.35 M)
(27.74 M)
(18.45 M)
308.33 M
106.6 M
(23.9 M)
Operating Margin
-2.63
N/A
-0.0738
-0.21
-0.93
-4.93
-0.65
0.35
-0.0734
0.082
Current Valuation
33.07 M
15.39 M
3.57 M
918.68 M
5.53 M
(3.21 M)
5.78 M
1.74 B
1.75 B
97.58 M
Price To Book
N/A
263.15
0.61
148.36
3.57
0.53
1.39
4.23
3.07
0.49
Retained Earnings
(11.24 M)
(16.34 M)
(174.36 M)
(558.98 M)
(21.65 M)
(53.36 M)
(99.65 M)
(233.19 M)
(80.13 M)
(204 M)
Current Asset
122 K
27.33 K
N/A
27.24 M
15.84 M
N/A
N/A
96.88 M
192.58 M
422.05 M
Beta
1.17
0.0021
1.99
1.32
1.0
1.52
0.51
0.95
0.71
0.033
Number Of Employees
6
1
52
322
69
N/A
83
197
642
270
Shares Outstanding
505.16 M
450.62 M
4.47 M
63.32 M
150.1 M
1.43 M
7.75 M
32.25 M
21.02 M
45.77 M
Cash Flow From Operations
(1.46 M)
(732.65 K)
(4.3 M)
(34.01 M)
(7.49 M)
(1.5 M)
(24.89 M)
274.75 M
118.96 M
(53.63 M)
Total Debt
3.37 M
200 K
3.68 M
126.55 M
1.4 M
4 M
5.4 M
674.28 M
285.67 M
195.68 M
Return On Equity
-12.09
-31.44
-1.35
-8.62
-2.36
-2.43
-1.49
0.43
-0.016
-0.14
Z Score
1.4
N/A
N/A
N/A
2.6
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.6
-2.71
-0.16
-0.0993
-0.52
-0.26
-0.4
0.0968
0.0125
-0.0024
Book Value Per Share
-0.016
N/A
0.8
0.093
0.009
3.52
3.16
7.27
20.74
9.64
Number Of Shares Shorted
N/A
N/A
205.96 K
5.29 M
N/A
86.9 K
316.57 K
6.29 M
2.11 M
16.23 K
Current Liabilities
2.46 M
2.04 M
N/A
76.8 M
3.01 M
N/A
N/A
8.43 M
11.76 M
474.59 M
Total Asset
5.22 M
186.91 K
16.2 M
189 M
18.07 M
8.84 M
27.93 M
1.14 B
904.42 M
786.61 M
Target Price
0.05
N/A
2.0
23.43
0.05
N/A
11.5
42.25
78.4
33.56
Debt To Equity
N/A
0.18
0.11
1.59
0.74
0.027
N/A
3.82
0.86
0.32
Short Ratio
N/A
N/A
0.83
8.04
N/A
0.11
0.08
15.69
8.25
0.39
Shares Owned By Institutions
N/A
N/A
3.32
80.21
N/A
N/A
20.6
98.36
99.72
11.61
Market Capitalization
26.77 M
10 M
2.2 M
866.87 M
7.85 M
2.43 M
7.67 M
990.4 M
1.2 B
61.78 M
Price To Earning
-10.0
-0.71
17.62
-5.55
54.89
N/A
N/A
28.8
43.35
37.77
Price To Earnings To Growth
N/A
N/A
N/A
-0.52
N/A
N/A
N/A
N/A
1.06
1.03
Price To Sales
19.81
2055.98
0.089
3.49
0.28
0.97
0.22
1.65
2.17
0.23
Net Income
(4.13 M)
(3.42 M)
(22.94 M)
(61.69 M)
(15.55 M)
(32.28 M)
(20.13 M)
48.16 M
18.78 M
(63.53 M)
Earnings Per Share
-0.018
-0.002
-10.9
-0.91
-0.13
-524.76
1.16
2.34
-0.47
-0.4
Shares Owned By Insiders
5.59
77.13
16.11
12.31
2.01
1.65
32.06
1.64
11.08
39.59
Revenue
1.28 M
1.52 K
24.16 M
202.09 M
20.05 M
2.16 M
34.07 M
566.77 M
486.82 M
355.55 M
Working Capital
(2.34 M)
(2.02 M)
3.4 M
64.13 M
12.83 M
(8.37 M)
4.99 M
79.69 M
374.34 M
192.94 M
Cash And Equivalents
6.56 K
189.68 K
10.55 M
84.48 M
1.11 M
N/A
31.91 M
122.72 M
63.38 M
305.06 M
Cash Per Share
N/A
N/A
0.17
1.51
0.01
N/A
1.36
3.6
3.89
2.92
Gross Profit
503.01 K
(71.16 K)
22.34 M
92.73 M
8.62 M
3.27 M
13.49 M
345.74 M
177.6 M
102.56 M
Day Typical Price
0.01
1.0E-4
0.49
13.86
0.04
1.74
0.91
30.68
57.76
1.34
Accumulation Distribution
11017.48
N/A
3523.71
27866.21
N/A
6537.72
55837.61
4345.25
9931.89
365.37
Daily Balance Of Power
(0.60)
0.0
(0.67)
(0.14)
0.0
0.4167
(0.75)
(0.31)
(0.82)
(0.50)
Period Momentum Indicator
(0.0003)
N/A
(0.02)
(0.11)
N/A
0.05
(0.09)
(0.21)
(2.16)
(0.02)
Rate Of Daily Change
0.97
1.0
0.96
0.99
1.0
1.03
0.91
0.99
0.96
0.99
Day Median Price
0.0101
1.0E-4
0.5
13.95
0.04
1.73
0.91
30.77
58.02
1.35
Price Action Indicator
(0.0002)
N/A
(0.01)
(0.31)
N/A
0.045
(0.06)
(0.37)
(1.87)
(0.03)
Relative Strength Index
52.22
N/A
35.41
26.68
52.68
39.32
42.39
31.38
63.83
24.98
Coefficient Of Variation
(4,084)
N/A
30559.58
(2,171)
10425.67
(1,386)
5340.35
(878.41)
(2,183)
(642.11)
Mean Deviation
6.04
N/A
3.18
2.54
4.1
3.54
6.21
1.87
1.94
2.96
Jensen Alpha
(0.07)
N/A
0.1131
(0.28)
0.3198
(0.53)
0.4076
(0.43)
(0.28)
(0.78)
Total Risk Alpha
(1.59)
N/A
(0.78)
(0.75)
(1.48)
(1.09)
(1.28)
(0.67)
(0.52)
(1.47)
Sortino Ratio
N/A
N/A
(0.03)
N/A
(0)
N/A
0.003
N/A
N/A
N/A
Downside Variance
N/A
N/A
22.0
N/A
416.67
N/A
59.31
N/A
N/A
N/A
Standard Deviation
8.28
N/A
4.68
3.47
9.37
4.52
8.57
2.36
2.41
4.52
Kurtosis
0.8298
N/A
3.75
4.28
3.24
0.6452
1.99
0.4702
0.0579
10.8
Potential Upside
15.38
N/A
6.82
5.06
25.0
8.0
14.63
3.23
3.7
5.79
Treynor Ratio
0.188
N/A
(0.01)
(0.21)
(0.04)
(0.23)
(0.07)
(0.24)
(0.1)
(1.38)
Maximum Drawdown
32.23
N/A
28.6
22.78
45.0
22.55
46.72
12.29
10.82
29.33
Variance
68.48
N/A
21.93
12.05
87.82
20.47
73.49
5.56
5.79
20.44
Market Risk Adjusted Performance
0.198
N/A
0.0037
(0.20)
(0.03)
(0.22)
(0.06)
(0.23)
(0.09)
(1.37)
Risk Adjusted Performance
(0.01)
N/A
0.0109
(0.03)
0.0165
(0.05)
0.0234
(0.08)
(0.03)
(0.11)
Skewness
(0.36)
N/A
1.0
(0.91)
0.5457
0.5481
0.8063
(0.35)
0.2984
2.14
Semi Deviation
N/A
N/A
3.69
N/A
6.56
N/A
7.25
N/A
N/A
N/A
Information Ratio
(0.04)
N/A
(0.03)
(0.09)
(0.01)
(0.10)
0.0027
(0.17)
(0.10)
(0.19)
Value At Risk
(14.53)
N/A
(7.41)
(4.70)
(20.00)
(6.67)
(11.70)
(4.47)
(3.75)
(6.88)
Expected Short fall
N/A
N/A
(4.58)
N/A
(19.42)
N/A
(7.22)
N/A
N/A
N/A
Downside Deviation
N/A
N/A
4.69
N/A
20.41
N/A
7.7
N/A
N/A
N/A
Semi Variance
N/A
N/A
13.6
N/A
43.01
N/A
52.55
N/A
N/A
N/A

Endexx Corp Competition Performance Charts

Five steps to successful analysis of Endexx Corp Competition

Endexx Corp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Endexx Corp in relation to its competition. Endexx Corp's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Endexx Corp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Endexx Corp's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Endexx Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Endexx Corp position

In addition to having Endexx Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Plastics Thematic Idea Now

Plastics
Plastics Theme
Companies manufacturing rubber and plastics accessories. The Plastics theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Endexx Pink Sheet

Endexx Corp financial ratios help investors to determine whether Endexx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endexx with respect to the benefits of owning Endexx Corp security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY